See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $9.8B | 8.0x | 22.8x | |
| $9.3B | n/a | n/a | |
| $2.5B | 11.0x | -62.5x | |
| $1.4B | 4.8x | -10.8x | |
| $1.1B | n/a | n/a | |
| $386M | 213.8x | -12.2x | |
| $312M | n/a | n/a | |
| $175M | 3.4x | 19.8x | |
| $153M | 50.1x | -7.8x | |
| $134M | 7.9x | 10.3x | |
| $130M | n/a | -2.0x | |
| $78.3M | 6.9x | -4.4x | |
| $49.3M | 2.8x | 15.1x | |
| $30.1M | 37.0x | -11.2x | |
| $28.3M | 17.0x | -17.2x | |
| $27.8M | 11.2x | -5.7x | |
| $19.0M | 0.7x | n/a | |
| $4.7M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics